Cytomegalovirus Retinitis Completed Phase 3 Trials for Valganciclovir (DB01610)

Also known as: CMV retinitis / Cytomegaloviral retinitis (disorder) / Cytomegalovirus chorioretinitis / Chorioretinitis caused by Cytomegalovirus (disorder)

IndicationStatusPhase
DBCOND0000283 (Cytomegalovirus Retinitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002377A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the EyesTreatment